thyssenkrupp nucera Returns to Profit Despite Green Hydrogen Market Challenges
TL;DR
thyssenkrupp nucera achieved positive EBIT despite sales decline, positioning investors to benefit from their market leadership in green hydrogen technology during the energy transition.
thyssenkrupp nucera reported EUR 845 million in sales with EUR 2 million EBIT, showing improved performance in the Green Hydrogen segment despite challenging market conditions.
thyssenkrupp nucera's continued advancement in green hydrogen technology supports global climate goals by enabling cleaner energy solutions for a more sustainable future.
thyssenkrupp nucera successfully turned a EUR 14 million loss into a EUR 2 million profit while pioneering industrial-scale green hydrogen production technology.
Found this article helpful?
Share it with your network and spread the knowledge!

thyssenkrupp nucera, the world's leading provider of electrolysis technologies, returned to profitability in the 2024/2025 fiscal year despite facing challenging market conditions for green hydrogen. The company reported earnings before interest and taxes (EBIT) of approximately €2 million, a significant improvement from the previous year's loss of €14 million, while sales declined slightly to €845 million from €862 million in the prior period.
The company's performance showed mixed results across its business segments. The Green Hydrogen (gH2) segment, which uses alkaline water electrolysis technology to produce climate-neutral hydrogen, achieved a significantly improved EBIT of €-56 million compared to €-76 million in the previous year, though sales declined to €459 million from €524 million. In contrast, the Chlor-Alkali (CA) segment demonstrated strong growth with sales increasing to €386 million from €338 million, while EBIT declined slightly to €58 million from €62 million.
Order intake for the fiscal year 2024/25 declined significantly to €348 million from €636 million in the previous year, with the gH2 segment accounting for only €26 million compared to €356 million previously. The order backlog as of September 30, 2025, stood at €0.6 billion, down from €1.1 billion in the prior year. The company generated positive free cash flow and continues to finance itself from operating activities.
Looking ahead to the 2025/2026 fiscal year, the Management Board expects consolidated sales to decline significantly to between €500 million and €600 million, with EBIT projected to range from €-30 million to €0 million. CEO Dr. Werner Ponikwar attributed the challenging outlook to "restraint in final investment decisions" and a deteriorating global economic environment affecting the green hydrogen market.
The company has initiated measures to reduce the impact of lower sales on cost coverage and earnings. Ponikwar emphasized that despite the challenges, thyssenkrupp nucera's positioning in hydrogen and chlor-alkali markets and strong financial resilience will help the company overcome current difficulties. Detailed explanations of the financial performance indicators used can be found in thyssenkrupp nucera's 2023/2024 Annual Report on pages 53 to 54.
This development is significant as thyssenkrupp nucera represents a key player in the global transition to clean energy through hydrogen technology. The company's return to profitability demonstrates progress in commercializing green hydrogen technology, while the projected decline highlights the ongoing challenges in scaling this emerging industry. The performance reflects broader market dynamics affecting the global hydrogen economy and the pace of energy transition investments worldwide.
Curated from NewMediaWire

